Litcius/Paper detail

Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020

Maureen J. Miller, Lanfang Xu, Jin Qin, Erin E. Hahn, Quyen Ngo‐Metzger, Brian S. Mittman, Devansu Tewari, Melissa Hodeib, Patricia Wride, Mona Saraiya, Chun Chao

2021MMWR Morbidity and Mortality Weekly Report167 citationsDOIOpen Access PDF

Abstract

On March 19, 2020, the governor of California issued a statewide stay-at-home order to contain the spread of SARS-CoV-2, the virus that causes coronavirus disease 2019 .* The order reduced accessibility to and patient attendance at outpatient medical visits, including preventive services such as cervical cancer screening. In-person clinic visits increased when California reopened essential businesses on June 12, 2020. Electronic medical records of approximately 1.5 million women served by Kaiser Permanente Southern California (KPSC), a large integrated health care system, were examined to assess cervical cancer screening rates before, during, and after the stay-at-home order. KPSC policy is to screen women aged 21-29 years every 3 years with cervical cytology alone (Papanicolaou [Pap] test); those aged 30-65 years were screened every 5 years with human papillomavirus (HPV) testing and cytology (cotesting) through July 15, 2020, and after July 15, 2020, with HPV testing alone, consistent with the latest recommendations from U.S. Preventive Services Task Force. Compared with the 2019 baseline, cervical cancer screening rates decreased substantially during the stay-at-home order. Among women aged 21-29 years, cervical cytology screening rates per 100 person-months declined 78%. Among women aged 30-65 years, HPV test screening rates per 100 personmonths decreased 82%. After the stay-at-home order was lifted, screening rates returned to near baseline, which might have been aided by aspects of KPSC's integrated, organized screening * https://covid19.ca.gov/img/N-33-20.pdf https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/Resumi ngCalifornia%E2%80%99sDeferredandPreventiveHealthCare.aspx https://covid19.ca.gov/safer-economy https://www.uspreventiveservicestaskforce.org/uspstf/

Topics & Concepts

MedicineCervical cancerAttendancePapanicolaou stainFamily medicinePap testCervical cancer screeningMedical recordGynecologyCancerPediatricsInternal medicineEconomic growthEconomicsCOVID-19 and healthcare impactsGlobal Cancer Incidence and ScreeningCervical Cancer and HPV Research